Insider · CIK 0001931514
Brenda Cooperstone
Files at SNTI (Senti Biosciences, Inc.), LXEO (Lexeo Therapeutics, Inc.). First filing -, latest -.
Brenda Cooperstone files SEC Form 4 as director at SNTI (Senti Biosciences, Inc.), and also at LXEO (Lexeo Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brenda Cooperstone has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 29, 2026 |
| Jun 26, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2025 |
| Jun 25, 2025 | SNTI Senti Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +21,950 | $0.00 | $0 | 21,950 | Jun 27, 2025 |
| Mar 7, 2025 | SNTI Senti Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +43,900 | $0.00 | $0 | 43,900 | Mar 11, 2025 |
Questions about Brenda Cooperstone
Answered from the filings on this page, as of the latest one.
Is Brenda Cooperstone buying or selling?
Brenda Cooperstone has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brenda Cooperstone's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brenda Cooperstone has 0.
Where does Brenda Cooperstone file Form 4?
Brenda Cooperstone has filed Form 4 at SNTI (Senti Biosciences, Inc.); LXEO (Lexeo Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.